...
首页> 外文期刊>Biochemistry >Kinetic characterization of protein arginine deiminase 4: A transcriptional corepressor implicated in the onset and progression of rheumatoid arthritis
【24h】

Kinetic characterization of protein arginine deiminase 4: A transcriptional corepressor implicated in the onset and progression of rheumatoid arthritis

机译:精氨酸脱亚氨酶4的动力学表征:类风湿关节炎的发作和发展的转录共抑制因子。

获取原文
获取原文并翻译 | 示例
           

摘要

Protein arginine deiminase 4 (PAD4) is a Ca2+-dependent enzyme that catalyzes the posttranslational conversion of arginine to citrulline (Arg -> Cit) in a number of proteins, including histories. While the gene encoding this enzyme has been implicated in the pathophysiology of rheumatoid arthritis (RA), little is known about its mechanism of catalysis, its in vivo role, or its role in the pathophysiology of RA; however, recent reports suggest that this enzyme can act as a transcriptional corepressor for the estrogen receptor. Herein, we report our initial kinetic and mechanistic characterization of human PAD4. Specifically, these studies confirm that PAD4 catalyzes the hydrolytic deimination of Arg residues to produce Cit and ammonia. The metal dependence of PAD4 has also been evaluated, and the results indicate that PAD4 activity is highly specific for calcium. Calcium activation of PAD4 catalysis exhibits positive cooperativity with K-0.5 values in the mid to high micromolar range. Evidence indicating that calcium binding causes a conformational change is also presented. Additionally, the steady-state kinetic parameters for a number of histone H4-based peptide substrates and benzoylated Arg derivatives have been determined. K-m, values for these compounds are in the high micromolar to the low millimolar range with k(cat) values ranging from 2.8 to 6.6 s(-1). The ability of PAD4 to catalyze the deimination of methylated Arg residues has also been evaluated, and the results indicate that these compounds are poor PAD4 substrates (V/K <= 31.3 M-1 s(-1)) in comparison to other substrates. These findings suggest that the full-length enzyme does not catalyze this reaction in vitro and possibly in vivo either. Collectively, the studies described herein will provide a firm foundation for the future development of PAD4 selective inhibitors.
机译:精氨酸脱亚氨酶4(PAD4)是一种Ca2 +依赖性酶,可催化包括历史在内的多种蛋白质中精氨酸向瓜氨酸的翻译后转化(Arg-> Cit)。尽管编码该酶的基因与类风湿关节炎(RA)的病理生理有关,但对其催化机制,其体内作用或在RA的病理生理中的作用知之甚少。但是,最近的报道表明该酶可以作为雌激素受体的转录共抑制因子。在这里,我们报告我们人类PAD4的初始动力学和机制表征。具体而言,这些研究证实PAD4催化Arg残基的水解脱氨反应,生成Cit和氨。还评估了PAD4对金属的依赖性,结果表明PAD4活性对钙具有高度特异性。 PAD4催化的钙活化在中高摩尔浓度范围内与K-0.5值表现出正协同作用。还提供了表明钙结合引起构象变化的证据。此外,已经确定了许多基于组蛋白H4的肽底物和苯甲酰化Arg衍生物的稳态动力学参数。这些化合物的K-m值在高微摩尔至低毫摩尔范围内,k(cat)值在2.8至6.6 s(-1)之间。还评估了PAD4催化甲基化Arg残基脱氨的能力,结果表明,与其他底物相比,这些化合物是较差的PAD4底物(V / K <= 31.3 M-1 s(-1))。这些发现表明全长酶在体外和可能在体内均不催化该反应。总之,本文所述的研究将为PAD4选择性抑制剂的未来发展提供坚实的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号